ææ°ã® Merck & Co Inc ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
9æ17æ¥ã®Moderna Inc (MRNA) å€åãã¯7.25%äžæïŒå€åãã®èåŸã«ããäºå®
9æ17æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯3.02%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
9æ11æ¥ã®Moderna Inc (MRNA) å€åãã¯8.63%äžæïŒå®å šãªåæ
8æ27æ¥ã®Moderna Inc (MRNA) å€åãã¯5.69%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
8æ26æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯3.32%äžèœïŒå€åãã®èåŸã«ããäºå®
8æ26æ¥ã®Summit Therapeutics Inc (SMMT) å€åãã¯8.95%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
8æ26æ¥ã®Moderna Inc (MRNA) å§å€ã¯5.46%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
8æ26æ¥ã®Eli Lilly and Co (LLY) å§å€ã¯3.57%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
8æ25æ¥ã®Novo Nordisk A/S (NVO) çµå€ã¯3.71%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
8æ25æ¥ã®Mckesson Corp (MCK) å€åãã¯3.25%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ